Michael P Dube Intellia Therapeutics, Inc. (NTLA) insider trading activity

NTLA Quotes by TradingView

Michael P Dube is VP, Chief Accounting Officer of Intellia Therapeutics, Inc.. Currently has a direct ownership of 57,137 shares of NTLA, which is worth approximately $616,508. The most recent transaction as insider was on Jul 02, 2025, when has been sold 2,503 shares (Common Stock) at a price of $9.95 per share, resulting in proceeds of $24,904. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.1K
4.2% 3M change
16.55% 12M change
Total Value Held $616,508

Michael P Dube Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 02 2025
SELL
Open market or private sale
$24,904 $9.95 p/Share
2,503 Reduced 4.2%
57,137 Common Stock
Mar 01 2025
BUY
Grant, award, or other acquisition
-
14,000 Added 19.01%
59,640 Common Stock
Jan 03 2025
SELL
Open market or private sale
$16,710 $12.18 p/Share
1,372 Reduced 2.92%
45,640 Common Stock
Oct 02 2024
SELL
Open market or private sale
$38,248 $19.01 p/Share
2,012 Reduced 4.1%
47,012 Common Stock
Jul 01 2024
BUY
Grant, award, or other acquisition
-
17,801 Added 26.64%
49,024 Common Stock
MPD

Michael P Dube

VP, Chief Accounting Officer
Cambridge, MA

Track Institutional and Insider Activities on NTLA

Follow Intellia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

News

Receive news related to Intellia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NTLA